Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024

Rhea-AI Summary

Ceribell (Nasdaq: CBLL), a commercial-stage medical technology company focusing on neurological condition diagnosis and management, has scheduled its Q3 2024 financial results release for November 12, 2024, after market close. The company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results. Investors can join via phone using access code 7168007 or watch the webcast through Ceribell's investor relations website.

News Market Reaction – CBLL

-0.73%

-0.73% Session move

In the trading session that priced this news, CBLL declined 0.73%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SUNNYVALE, Calif., Oct. 29, 2024 /PRNewswire/ -- Ceribell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Tuesday, November 12, 2024. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 7168007. A live and archived webcast of the event will be available in the "Investor Relations" section of the Ceribell website at https://investors.ceribell.com/. 

About Ceribell Inc.
Ceribell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Ceribell System is an AI-powered, rapidly deployable point-of-care electroencephalography ("EEG") platform designed to address the unmet needs of patients in the acute care setting. The company is headquartered in Sunnyvale, Calif.

Investor Contact
Brian Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com

Media Contact
Corrie Rose
Press@ceribell.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ceribell-to-report-third-quarter-2024-financial-results-on-november-12-2024-302290488.html

SOURCE Ceribell, Inc.

FAQ

When will Ceribell (CBLL) release Q3 2024 earnings?

Ceribell will release its Q3 2024 financial results on November 12, 2024, after the market closes.

How can I listen to Ceribell's (CBLL) Q3 2024 earnings call?

Investors can listen to the call by dialing (800) 715-9871 (domestic) or (646) 307-1963 (international) with access code 7168007, or via webcast at investors.ceribell.com.

What time is Ceribell's (CBLL) Q3 2024 earnings call?

Ceribell's Q3 2024 earnings conference call will begin at 1:30 p.m. PT / 4:30 p.m. ET on November 12, 2024.